Dyslipidaemia
Conditions
Interventions
None listed
Sponsors
Otsuka Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 18 years or older with dyslipidaemia who have LDL-C test results between 1 August 2022 and 31 March 2024.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients who did not achieve the target LDL-C level, which was higher than the target level | — |
Secondary
| Measure | Time frame |
|---|---|
| Odds ratios for each covariate in patient groups eligible for secondary prevention and high-risk primary prevention based on JAS GL2022. | — |
Countries
Japan
Contacts
Public ContactTakuya Maekawa
Otsuka Pharmaceutical Co., Ltd. Medical Affairs
Outcome results
None listed